ask="4.90"
ask_size="2000"
average_daily_volume="10832"
bid="4.10"
bid_size="500"
book_value="-2.05"
change="+0.15"
change_from_200_day_moving_average="-0.23"
change_from_50_day_moving_average="-0.17"
change_from_52_week_high="-1.41"
change_From_52_week_low="3.74"
change_in_percent="+3.71%"
close="4.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.88"
ebitda="-3.99M"
eps_estimate_current_year="-2.95"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2882000"
high="4.30"
high_52_weeks="5.60"
last_trade_date="2/24/2017"
last_trade_price="4.19"
last_trade_size="402"
last_trade_time="4:00pm"
low="4.01"
low_52_weeks="0.45"
market_capitalization="40.35M"
moving_average_200_day="4.42"
moving_average_50_day="4.36"
name="AzurRx BioPharma
Inc."
notes="N/A"
one_year_target_price="7.00"
open="4.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-5.12%"
percent_change_from_50_day_moving_average="-3.82%"
percent_change_from_52_week_high="-25.18%"
percent_change_from_52_week_low="+831.11%"
previous_close="4.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9631000"
short_ratio="1.01"
stock_exchange="NCM"
symbol="AZRX"
volume="63604"
weeks_range_52="0.45 - 5.60"
